Pharmaceutical Industry Related Content
The UK’s legalisation of medicinal cannabis
David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.
Targeted policy support for emerging biomedical innovations
Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.
COVID-19 update: Vaccinations & infection prevention and control (IPC)
Ruth Smith CEO of Active Care Group and its Christchurch Group division discusses the new highly virulent variant of COVID, vaccinations, and infection prevention and control (IPC).
EU allocates additional €500 million to COVAX facility
The European Union has allocated an additional €500 million to the COVAX facility, bringing its total contribution to €1 billion.
Heart failure drug may treat COVID-19 long-hauler symptom
Researchers have found that an existing heart failure drug can improve the symptoms associated with postural orthostatic tachycardia syndrome.
COVID-19 and drugs in the European neighbourhood partnership countries
The EU drugs agency explores the impact of COVID-19 on drug markets, use and services in the European neighbourhood partnership countries.
Medical cannabis in the UK and the industry’s future
Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry.
UK Government and CureVac partnership to tackle COVID-19 virus variants
The UK Government and vaccine manufacturer CureVac have partnered to rapidly develop new vaccines in response to new COVID-19 virus variants.
UK regulator assures safety of COVID-19 vaccines
Recent data published by the UK’s independent medicines regulator assures the Pfizer/BioNTech and the Oxford University/AstraZeneca vaccines meet strict regulatory standards for safety
Innovate UK invests £900k into cloud-based pharmacy dispensary software
Innovate UK has invested a further £900k of funding into Titan, a cloud-based medicine dispensary software for pharmacies.
Drug prices in the U.S. are 2.56 times higher
Prescription drug prices in the United States are 2.56 times higher than in other countries, according to a new RAND Corporation report.
Antibiotics provide no benefit to COVID-19 patients
The PRINCIPLE trial has found that azithromycin and doxycycline do not provide any recovery benefits for COVID-19 patients.
Studies show promising results for new Oxford COVID-19 vaccine
Studies show that the new Oxford-produced RBD-SpyVLP COVID-19 vaccine produces a strong antibody response in mice and pigs.
EU finalises talks with Valneva to secure a new vaccine
Today, the European Commission concluded talks with Valneva to secure a new potential vaccine against COVID-19.
Open Access Government January 2021
The January 2021 edition of Open Access Government discusses global government policy issues, such as COVID-19, health & social care, research & innovation, digital transformation, economic development, agriculture, environment and energy.
Kim Schleppegrell Skaue joins Oils By Simpson: Their mission to promote natural medicine
Read on to find out more about Oils By Simpson, Kim Schleppegrell Skaue, and their joint mission to encourage natural medicine use worldwide.
Functionality of Hemp Proteins and their Peptides
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains why hemp protein is gaining a reputation as nutraceutical product.
CBD oil and cancer: What the research shows
CBD oil has long been utilised for its various therapeutic effects, but what about its effect on cancer? Read on to find out more about what the research shows.
Rapid and successful adaptation of a national teaching programme to COVID-19
Dr Andrew McIndoe MBE & Dr Ed Hammond MBE chart the rapid and successful adaptation of delivery of a national teaching programme to the COVID-19 pandemic.
Can we live without pharmacology?
Aida Batista, Vice President of the European Association of Hospital Pharmacists (EAHP), explores if we can live without pharmacology, including comment on the use of opioid and sedative drugs.
